Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
11/30/1994 | CN1095619A Health-care tortoise and soft-shelled turtle capsule and its prepn. method |
11/30/1994 | CN1095617A Application of ginseng, and its vigour strengthening instant powder and prepn. method |
11/30/1994 | CN1095591A Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor |
11/30/1994 | CN1026789C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
11/29/1994 | US5369110 Biphenylyl compounds |
11/29/1994 | US5369108 Potent inducers of terminal differentiation and methods of use thereof |
11/29/1994 | US5369103 Piperazine derivatives |
11/29/1994 | US5369094 Polypeptide bombesin antagonists |
11/29/1994 | US5368858 Methods and compositions for the treatment and repair of defects or lesions in cartilage |
11/29/1994 | CA2124252A1 Method of reducing or preventing bone marrow hypoplasia |
11/28/1994 | CA2124277A1 Methods for administering biological agents and microparticle compositions useful in these and other methods |
11/26/1994 | CA2122886A1 Saccharin derivative proteolytic enzyme inhibitors |
11/25/1994 | CA2124048A1 Aryl substituted heterocycles |
11/24/1994 | WO1994026893A1 Bmp-10 compositions |
11/24/1994 | WO1994026892A1 Bmp-11 compositions |
11/24/1994 | WO1994026888A1 Inhibition of proliferation of vascular smooth muscle cell |
11/24/1994 | WO1994026876A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
11/24/1994 | WO1994026747A1 Ampa antagonists and a method of treatment therewith |
11/24/1994 | WO1994026739A1 1,4-benzoxazine derivatives as potassium channel openers |
11/24/1994 | WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
11/24/1994 | WO1994026714A1 Novel deoxygalactonojirimycin derivatives |
11/24/1994 | WO1994026710A1 INDOLE DERIVATIVES AS TESTOSTERONE 5α-REDUCTASE INHIBITORS |
11/24/1994 | WO1994026707A1 Vitamin d amide derivatives |
11/24/1994 | WO1994026702A1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
11/24/1994 | WO1994026664A1 Large potassium bicarbonate crystals and process for the preparation thereof |
11/24/1994 | WO1994026322A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
11/24/1994 | WO1994026310A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent |
11/24/1994 | WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
11/24/1994 | WO1994026303A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
11/24/1994 | WO1994026301A1 New peptide antagonists at glutamate and nmda receptors |
11/24/1994 | WO1994026298A1 Methods for treating muscle diseases and disorders |
11/24/1994 | WO1994026291A1 Therapeutic inhibitor of vascular smooth muscle cells |
11/24/1994 | WO1994026285A1 Xenograft thymus |
11/24/1994 | WO1994026283A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
11/24/1994 | WO1994026277A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
11/24/1994 | WO1994026274A1 Treatment process with biologically active tropane derivatives |
11/24/1994 | WO1994026270A1 Transdermal therapeutic systems for the administration of serotonin agonists |
11/24/1994 | WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
11/24/1994 | WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions |
11/24/1994 | CA2163234A1 Inhibition of proliferation of vascular smooth muscle cell |
11/24/1994 | CA2163095A1 Treatment process with biologically active tropane derivatives |
11/24/1994 | CA2162990A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
11/24/1994 | CA2162853A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
11/24/1994 | CA2162272A1 Vitamin d amide derivatives |
11/24/1994 | CA2161978A1 Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton |
11/24/1994 | CA2161807A1 Bmp-10 compositions |
11/24/1994 | CA2161797A1 Xenograft thymus |
11/24/1994 | CA2161648A1 Compositions and methods for reparation and prevention of fibrotic lesions |
11/24/1994 | CA2160776A1 Transdermal therapeutic systems for the administration of serotonin agonists |
11/23/1994 | EP0625509A1 N-alkyl substituted piperidine-derivatives with neurokinin receptor antagonist activity |
11/23/1994 | EP0625355A1 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient |
11/23/1994 | EP0625163A1 Parathyroid hormone fragments, their preparation and medicaments containing the same |
11/23/1994 | EP0625149A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists |
11/23/1994 | EP0549666B1 Novel aminobenzosultam derivatives as lipoxygenase inhibitors |
11/23/1994 | EP0522013B1 Novel vitamin d analogues |
11/23/1994 | EP0429464B1 Bivalent ligands effective for blocking acat enzyme |
11/23/1994 | CN1095378A 3-(6-Qinolylmethyl)-4H-imidazol-4-one derivatives, their preparation and their application in therapy |
11/23/1994 | CN1095375A Novel sulfonamides |
11/23/1994 | CN1095374A Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease |
11/23/1994 | CN1095293A Iodine-containing seaweed health-care preparation and its preparing method |
11/23/1994 | CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
11/23/1994 | CN1095267A Tablets with improved bioavailability of the active material clodronic acid |
11/22/1994 | US5367079 Lipoxygenase inhibitors; antiinflammatory agents, antiallergens |
11/22/1994 | US5366994 Enzyme inhibitors |
11/22/1994 | US5366987 Enzyme inhibitors, anticholesterol |
11/22/1994 | US5366982 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene B4 antagonist activity, their preparation and use in pharmaceutical compositions |
11/22/1994 | US5366973 Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyridazine pyrazolo[1,2]pyridazine, pyridazol[1,2-a][1,2]diazepine and pyrazolol[1,2-a][1,2]diazepine |
11/22/1994 | US5366967 Potentiation of the anti-reactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
11/22/1994 | US5366735 Method and composition for post-surgical adhesion reduction |
11/22/1994 | CA1333124C Antioxidant compositions and methods |
11/18/1994 | CA2123636A1 Alkyl substituted heterocycles |
11/17/1994 | EP0624645A1 Human chondromodulin-I protein |
11/17/1994 | EP0624593A2 Bile acid derivates, a method for their production and their use as medicines |
11/17/1994 | EP0624590A1 N-acylated staurosporine derivatives, process and intermediates for their preparation and their use as medicaments |
11/17/1994 | EP0624589A2 Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
11/17/1994 | EP0624584A1 Piperazine derivatives useful as calmodolin inhibitors |
11/17/1994 | EP0624583A1 Substituted mono- and bipyridylmethylpyridone as angiotensine II antagonists |
11/17/1994 | EP0624582A1 Substituted benzodioxine, process for their preparation and pharmaceutical compositions containing them |
11/17/1994 | EP0624574A2 Novel prostaglandin analogue |
11/17/1994 | EP0624573A1 Iodo vitamin D3 compounds and method for preparing same |
11/17/1994 | EP0624569A1 NMDA antagonists |
11/17/1994 | EP0624371A1 Microcapsules for controlled release of acetylsalicylic acid |
11/17/1994 | EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly. |
11/17/1994 | EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
11/17/1994 | EP0624159A1 Pyridyl substituted imidazoles |
11/17/1994 | EP0624156A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
11/16/1994 | CN1095062A Preparation of pure enantiomorisomer |
11/16/1994 | CN1026588C Novel 1-alkyl substituted benzimidazole derivatives |
11/15/1994 | US5364943 Preparation of substituted piperidines |
11/15/1994 | US5364942 Sulphonylbenzyl-substituted imidazopyridines |
11/15/1994 | US5364856 Modification of serotonin function |
11/15/1994 | US5364853 Treatment of disorders associated with vascular, respiratory, gastrointestinal tract, urinary bladder or uterus smooth muscle contraction |
11/15/1994 | US5364846 N-cycloalkylaminoethane-1,1-bis (phosphonic acid) useful for the treatment of osteoporosis and degenerative joint disease |
11/15/1994 | US5364840 Synthetic calcitonin peptides |
11/15/1994 | US5364839 Osteoinductive pharmaceutical formulations |
11/15/1994 | US5364652 Potato starch treated with heat and hydrochloric acid and hydrolyzed with amylase and glucoamylase; dietetics; fibers; foods |
11/14/1994 | CA2123243A1 Substituted mono- and bipyridylmethylpyridones |
11/13/1994 | CA2123261A1 Urethanes and ureas that induce cytokine production |
11/12/1994 | CA2123163A1 Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
11/12/1994 | CA2122937A1 Human chondromodulin-i protein |